Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Documentation of In-Process Control Results – V 2.0

Posted on By

API Manufacturing: SOP for Documentation of In-Process Control Results – V 2.0

Standard Operating Procedure for Documentation of In-Process Control Results in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/087/2025
Supersedes SOP/API/087/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standard procedure for documenting all in-process control (IPC) test results generated during the manufacture of Active Pharmaceutical Ingredients (APIs), ensuring traceability, accuracy, and compliance with GMP and data integrity principles.

2. Scope

This SOP applies to the documentation of IPC tests performed by production and QC personnel throughout the manufacturing lifecycle of intermediates and

APIs, including parameters such as pH, LOD, temperature, yield, appearance, and assay.

3. Responsibilities

  • Production Chemist/Operator: Record IPC results promptly in the BMR and applicable logbooks.
  • QC Analyst: Review and verify the IPC results and record them in lab worksheets.
  • QA Officer: Review completed documentation for correctness and compliance.
See also  API Manufacturing: SOP for Blending of Final Dried API - V 2.0

4. Accountability

Production Head is accountable for complete and accurate recording of IPC results. QA Head is responsible for reviewing and ensuring data integrity and traceability.

5. Procedure

5.1 IPC Parameters and Records

  1. IPC parameters shall be defined in the Master Formula Record (MFR) and include:
    • Appearance
    • pH
    • LOD
    • Conductivity
    • Assay
    • TLC or HPLC results
    • Temperature and time records
  2. These shall be recorded during sampling or observation, using indelible ink (blue/black only) in the Batch Manufacturing Record (BMR).

5.2 Recording of Results

  1. Enter values in the respective IPC table format within the BMR at the time of observation or immediately after analysis.
  2. Each entry shall include:
    • Result
    • Date and time
    • Initials of person performing the test
  3. Use “NA” (Not Applicable) if a test is not required; do not leave fields blank.
  4. Use “NR” (Not Recorded) only when a result is unavailable due to an explainable reason, and document justification.
See also  API Manufacturing: SOP for Calibration of Storage Vessels - V 2.0

5.3 Corrections and Deviations

  1. For corrections:
    • Strike through the incorrect entry with a single line.
    • Do not use correction fluids.
    • Write the correct entry, sign, date, and provide reason for correction.
  2. For any result falling outside the specification:
    • Stop processing immediately.
    • Notify QA and initiate deviation documentation as per relevant SOP.

5.4 Archiving and Retention

  1. All IPC records must be attached to the BMR and stored in the QA archive room.
  2. Electronic records, if applicable, must comply with 21 CFR Part 11 standards.
  3. Retention period: Minimum of 5 years or as per regulatory/customer requirement.

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • MFR: Master Formula Record
  • QA: Quality Assurance
  • QC: Quality Control
  • LOD: Loss on Drying
See also  API Manufacturing: SOP for Safety Measures in Solvent Recovery Operations - V 2.0

7. Documents

  1. In-Process Control Results Logbook (Annexure-1)
  2. Batch Manufacturing Record
  3. Deviation Form (if applicable)

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – US FDA cGMP
  • WHO TRS 986 – Good Manufacturing Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: In-Process Control Results Logbook

Date Batch No. Parameter Observed Value Limits Performed By Remarks
13/04/2025 API-20250413 LOD 0.88% NMT 1.0% Within limits

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Process Control Compliance QA Head
13/04/2025 2.0 Added electronic documentation provisions and NA/NR handling Audit Recommendation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Managing Subject Dropouts and Replacements in BA/BE Studies – V 2.0
Next Post: Analytical Method Development: Software Validation in AMD Lab – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version